Developer of a healthcare financial engagement platform designed to manage the patient payment ecosystem.
Developer of a healthcare financial engagement platform designed to manage the patient payment ecosystem.
Enterprise Systems (Healthcare)📍 New York, NYFounded 2016
Current Valuation
$3.2B
as of 2021-Q2
UNICORN
QL Price
$3.2B
0% vs last round
QuantLogix's current estimate for Cedar, published 2026-09-27 — in line with the last disclosed round of $3.2B (2021-Q2).
Confidence
medium
Basis
secondary led
What backs this price
Last disclosed round
$3.2B
2021-Q2
weight 0.03
Secondary market print
$3.2B
2026-06-27
weight 0.58
How this price has held up
No round has priced for Cedar since QuantLogix began publishing a price for it, so there is nothing to grade yet. The claim above is on the record from 2026-09-27 and will be graded against the next priced round. See the full accuracy record →
Which publicly-traded funds already hold it, what $10,000 buys, and whether any route is open to you.
Cite this price as QuantLogix QL Price, Cedar, 2026-09-27 (808d357e2dc87f4c).
The id pins this exact claim, so a citation stays checkable after the price moves.
Model estimate for research — not a quote, target price, or investment advice.
IPO Outlookprivate
Is Cedar going public?
No. Cedar is private and has not filed to go public. There is no S-1 on file.
What is Cedar's valuation in 2026?
Cedar is valued at $3.2B as of 2021-Q2, set by its Later Stage VC ($268.36M, Jun 2021). That is the last confirmed mark, not a live price — private shares do not trade continuously.
Has Cedar filed an S-1?
No public S-1 is on file for Cedar.
How much has Cedar raised?
Cedar has raised $6.2B in total, most recently a Later Stage VC of $268.36M in Jun 2021.
Is Cedar publicly traded — can you buy Cedar stock?
No. Cedar is a private company — its shares are not listed on any exchange and there is no ticker. The routes to exposure are pre-IPO secondary marketplaces and funds (accredited investors), employee tender offers when the company runs one, and public companies with read-through exposure. QuantLogix maps every route it can verify for Cedar on its Pre-IPO Access Desk.
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.
Company Profile
Founded
2016
HQ
New York, NY
Employees
389
Total Raised
$6.2B
Last Round
Later Stage VC — $268.36M (Jun 2021)
IPO Status
private
Fundraising Status
Later Stage VC · $268.36M · 5y 3mo ago
privateTotal raised $6.2B
Secondary Market
Implied price / share
$23.55
Open interest
6
Secondary price return by period
Implied per-share price from private secondary transactions, as of Jun 2026. This is a point estimate, not a quote — the feed carries no bid, ask or spread, and a secondary print is evidence of what someone paid on that date rather than a live market. The feed’s last-round price for this company is not a plausible per-share figure, so no comparison is shown. Compare across every tracked name →
Latest Funding Round
Round
Amount
Date
Lead Investor
Post-Money
Later Stage VC
$268.36M
Jun 2021
—
$3.2B
Talent Signal
Hiring trend
▶ Hiring steady
0% vs 2026-08
Open roles
3
via ashby
Product-build share
33%
engineering, research, product, design
Trajectory
steady
balanced build + GTM — 33% builders vs 67% go-to-market/G&A — scaling both sides.
Actively hiring with no tracked executive churn.
Open roles by month
Open roles by function
■ product-building ■ go-to-market / G&A
Mid Level Front End EngineerCedar Home AdvisorHead of Transaction Support and Admin
Counted from Cedar's live job board as of 2026-09-15; role functions classified from posting titles. Open-role counts are an activity signal, not headcount. Refreshed monthly.
MedicalPaymentsHealth CareFinTechBilling
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2021-Q2. Refreshed quarterly.